Annual ROA
-21.89%
+14.68%+40.14%
December 31, 2022
Summary
- As of February 10, 2025, JNCE annual return on assets is -21.89%, with the most recent change of +14.68% (+40.14%) on December 31, 2022.
- During the last 3 years, JNCE annual ROA has fallen by -48.93% (-180.95%).
Performance
JNCE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROA
-24.79%
+35.55%+58.92%
December 31, 2022
Summary
- As of February 10, 2025, JNCE quarterly return on assets is -24.79%, with the most recent change of +35.55% (+58.92%) on December 31, 2022.
- Over the past year, JNCE quarterly ROA has increased by +7.93% (+24.24%).
Performance
JNCE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
JNCE ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.1% | +24.2% |
| 3 y3 years | -180.9% | -191.3% |
| 5 y5 years | -278.1% | -376.7% |
JNCE ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.1% | at high | +143.4% |
| 5 y | 5-year | -181.0% | +67.1% | -191.3% | +143.4% |
| alltime | all time | -181.0% | +539.2% | -168.8% | +154.2% |
Jounce Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -21.89%(-40.1%) | -24.79%(-58.9%) |
| Sep 2022 | - | -60.34%(+14.3%) |
| Jun 2022 | - | -52.79%(+41.1%) |
| Mar 2022 | - | -37.42%(+14.4%) |
| Dec 2021 | -36.57%(+87.7%) | -32.72%(+230.8%) |
| Sep 2021 | - | -9.89%(+13.9%) |
| Jun 2021 | - | -8.68%(-59.4%) |
| Mar 2021 | - | -21.39%(-9.5%) |
| Dec 2020 | -19.48%(-172.0%) | -23.63%(-58.0%) |
| Sep 2020 | - | -56.29%(-596.4%) |
| Jun 2020 | - | 11.34%(-46.2%) |
| Mar 2020 | - | 21.06%(-22.4%) |
| Dec 2019 | 27.04% | 27.15%(-24.6%) |
| Sep 2019 | - | 36.03%(-374.2%) |
| Jun 2019 | - | -13.14%(+17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -11.22%(+4.5%) |
| Dec 2018 | -10.71%(+85.0%) | -10.74%(-14.8%) |
| Sep 2018 | - | -12.60%(+19.7%) |
| Jun 2018 | - | -10.53%(+11.9%) |
| Mar 2018 | - | -9.41%(+81.0%) |
| Dec 2017 | -5.79%(+14.7%) | -5.20%(+900.0%) |
| Sep 2017 | - | -0.52%(-124.8%) |
| Jun 2017 | - | 2.10%(-362.5%) |
| Mar 2017 | - | -0.80%(-83.9%) |
| Dec 2016 | -5.05%(-90.6%) | -4.97%(-71.7%) |
| Sep 2016 | - | -17.59%(-72.1%) |
| Jun 2016 | - | -63.01%(+58.8%) |
| Mar 2016 | - | -39.69%(+107.4%) |
| Dec 2015 | -53.86%(-61.5%) | -19.14% |
| Dec 2014 | -139.93% | - |
FAQ
- What is Jounce Therapeutics annual return on assets?
- What is the all time high annual ROA for Jounce Therapeutics?
- What is Jounce Therapeutics annual ROA year-on-year change?
- What is Jounce Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Jounce Therapeutics?
- What is Jounce Therapeutics quarterly ROA year-on-year change?
What is Jounce Therapeutics annual return on assets?
The current annual ROA of JNCE is -21.89%
What is the all time high annual ROA for Jounce Therapeutics?
Jounce Therapeutics all-time high annual return on assets is 27.04%
What is Jounce Therapeutics annual ROA year-on-year change?
Over the past year, JNCE annual return on assets has changed by +14.68% (+40.14%)
What is Jounce Therapeutics quarterly return on assets?
The current quarterly ROA of JNCE is -24.79%
What is the all time high quarterly ROA for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly return on assets is 36.03%
What is Jounce Therapeutics quarterly ROA year-on-year change?
Over the past year, JNCE quarterly return on assets has changed by +7.93% (+24.24%)